Multiple sclerosis drugs on Blue MedicareRx Plus (S5726-014)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Kansas
- Premium
- $67.40/month
- Deductible
- None
4 of 8 Multiple sclerosis drugs are covered on this plan. All 4 require prior authorization.
4 aren't on the formulary, including teriflunomide and Mayzent.
- $15,084.41Tier 5
- from $94.50Tier 4
- $2,943.86Tier 5
- $97.46Tier 4
Not on the formulary
teriflunomide, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.